All Michael Oredsson articles
-
News€20 million EIB venture debt financing to support microbiome research and development
The EIB has signed €20 million in venture debt financing with Belgian microbiome health company The Akkermansia Company to accelerate the R&D and commercial activities around the Akkermansia muciniphila bacterium.
